Testify
Website offline since 2026-10-19Test your website performance.
testify.adityacodes.tech Design / UI/UX Design & Prototyping
- Monthly visits
- None yet
- No traffic data yet
- Public revenue
- Undisclosed
- No public revenue evidence yet
- Entry price
- Unknown
- No monthly subscription pricing
- Launched
- 2y ago
- 2024-10-08 · Est.
Traffic
No traffic data yet.
Marketing moves
Launches, search & content, referrals, promotions- anthropic ipo is hereee it should start trading nov 19 and the q3 numbers are crazyy > $17b revenue, 12x+ last year's q3 > 11,900+ customers spent $100k+ in the last year > compute 4x more efficient since early 2025 4x more efficient and
@adityashipshq · 2026-11-12 · 0 likes · 0 reposts · 33 views
- Hey @grok, $200 a month on Claude Max or $200 of ANT 引用帖 @anthropicai： Our initial public offering: https://ipo.anthropic.com/ Legal disclaimer: Anthropic has filed a registration statement (including a prospectus) with the SEC for the of
@adityashipshq · 2026-11-12 · 0 likes · 0 reposts · 22 views
- every codex user right now 💀 引用帖 @thsottiaux： Thursday is feeling codexy to me. Perhaps also a good time for a banked reset.
@adityashipshq · 2026-11-12 · 0 likes · 0 reposts · 16 views
Traffic sources
Traffic breakdown
No traffic channel or country breakdown data for this website yet.
Search
Domain authority —Domain registered Unknown
No search keyword data for this website yet.
Traffic data: Vaneform
Pricing
Pricing page not identified yet, or no public pricing listed.
Pages & changes
Key pages
Weekly snapshotsNo page snapshots yet. Once followed, home and pricing pages are captured weekly.
Changes
No pricing, plan, or positioning changes detected since tracking started.
Questions & evidence
- What is Testify and what platforms does it support?
- Testify is catalogued under UI/UX Design & Prototyping: Test your website performance.. Supported platforms: Web.
Related products in this category
These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.